🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The antiviral nasal spray produced by our portfolio company SaNOtize Research and Development reduces 99% of #COVID19 viral load within 48 hours of treatment, The Lancet reports. glenmark For more information on investing in SaNOtize: hubs.ly/Q01h--_V0

Happy to announce a successful, oversubscribed funding round that will help us advance indications on our NORS platform technology. businesswire.com/news/home/2022…

We would like to clarify a general misconception between nitrous oxide and nitric oxide, as mistakenly referenced below. These are not the same molecules and have very different effects in the body. The nitric oxide in our products acts as an anti-microbial.

fiercepharma.com/pharma/sanotiz… Fierce Pharma highlights our platform technology:

Money briefing: SaNOtize Research and Development, AltFee Solutions Inc., Fineqia, and more vantechjournal.com/p/money-briefi…

We are excited to announce that Nitric Oxide Nasal Spray (NONS™) has been shortlisted as one of the finalists for the Fierce Innovation Awards: Life Sciences Edition 2022! We want to thank Fierce Life Sciences Events for their consideration. #FierceLifeSciencesAwards #nitricoxide #innovation

We congratulate this year’s Fierce Life Sciences Events Fierce Innovation Awards: Life Sciences Edition 2022 winner, Lyndra® Therapeutics for their LYNX drug delivery platform. This is a well-deserved recognition, and we are honoured to be shortlisted with you! #FierceLifeSciencesAwards #innovation

A big thanks to Viromed, our partner in Germany, who ran a very busy VirX booth at the MEDICA in Düsseldorf this week. We look forward to our continued relationship. #biotechnology #MEDICA2022

The #tech world’s most inspiring women leaders, inc Mdrew, of IBM, a founding member of wlda_tech, Gilly Regev CEO anti-Covid spray SaNOtize Research and Development, Dole Packaged Foods's Lara Ramdin & many more will gather at OurCrowd's global summit in Jerusalem. Register summit.ourcrowd.com/?utm_source=tw…

𝟴 𝑑𝑎𝑦𝑠 𝑜𝑓 𝐻𝑎𝑛𝑢𝑘𝑘𝑎ℎ 𝟵 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡 𝑤𝑎𝑦𝑠 𝑡𝑜 𝑠𝑝𝑒𝑙𝑙 𝑖𝑡. 𝟏𝟎 𝑚𝑜𝑟𝑒 𝑑𝑎𝑦𝑠 𝑢𝑛𝑡𝑖𝑙 𝑡ℎ𝑒 𝑒𝑛𝑑 𝑜𝑓 𝑜𝑢𝑟 ℎ𝑜𝑙𝑖𝑑𝑎𝑦 𝑑𝑖𝑠𝑐𝑜𝑢𝑛𝑡. Seize it before the lights go out. Enter promo code OCSUMMIT20 👉 summit.ourcrowd.com/?utm_source=tw…

"We are very excited to welcome John Sharp, who comes to SaNOtize at a transformative time in the evolution of the company,” said SaNOtize CEO and co-founder Gilly Regev, PhD. businesswire.com/news/home/2023…

Exciting news! Our inaugural scientific advisory board, made up of top leaders from Canada, US & Europe, will guide our innovative product pipeline, clinical development, and growth opportunities.#patientaccess #healthcareequity #advisoryboard #nitricoxide businesswire.com/news/home/2023…

We’re celebrating International Day of Women and Girls in Science with our own Dr. Gilly Regev! Her 20+ years in scientific research and development set an aspirational example of perseverance as a woman in STEM. #February11  #InternationalDayofWomenandGirlsinScience

Gilly Regev is featured in Medium's series "Why We Need More Women Founders,” in which she discusses the story of SaNOtize and the challenges she overcame to get to where she is today. Read the interview here: medium.com/authority-maga… #interview #womenempowerment

Nitric oxide nasal spray by SaNOtize Research and Development is being touted as an innovative anti-viral spray, proven effective in preventing viruses, including #COVID19 from entering the nasal cavity. Shruti Mishra talks to Co-founder Chris Miller to find out more. OurCrowd #Enovid #NoseSanitizer

ECRAID-Prime and SaNOtize Research and Development Corp. have signed a collaboration agreement to begin the first study of SaNOtize’s antiviral nitric oxide nasal spray (NONS), using Europe’s adaptive platform trial in primary care. ecraid.eu/news/ecraid-pr…

📬 The latest Ecraid newsletter announces an exciting collaboration between ECRAID-Prime and SaNOtize Research and Development, our newly adopted Gender Equality Plan, upcoming training opportunities in partnership with ESCMID, and more. Read it here 👉🏼 us9.campaign-archive.com/?u=c80b2aa31bc…

LSBC JOB BOARD: SaNOtize Research and Development is seeking two full-time positions. Learn more about the positions below: Director of Clinical Affairs: lifesciencesbc.ca/job/director-o… Director of Regulatory Affairs: lifesciencesbc.ca/job/director-o…

Exciting news! We’ve given our website a refresh – it’s got a new look and more information about what we do, why we do it, and the reasons to be excited about the promise of nitric oxide. Please visit us at sanotize.com #WebsiteRedesign #nitricoxide #innovation

RETURNING MEMBER: SaNOtize Research and Development is a Vancouver-based biotechnology company that has developed a proprietary method to deliver nitric oxide to the site of infection effectively. They are also developing products for other healthcare applications. Learn more: ow.ly/ihjX50PFHR2